TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1

Author(s):
Jahn, L.; Hombrink, P.; Hagedoorn, R.S.; Kester, M.G.D.; Steen, D.M. van der; Rodriguez, T.; Pentcheva-Hoang, T.; Ru, A.H.; Schoonakker, M.P.; Meeuwsen, M.H.; Griffioen, M. (0000-0002-3001-4441); Veelen, P.A. van (0000-0002-7898-9408); Falkenburg, J.H.F.; Heemskerk, M.H.M. (0000-0001-6320-9133)
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-03-09
Language
English
Is part of
Blood (2017), Vol. 129, no. 10, p. 1284-1295
hdl
1887/114878
doi
10.1182/blood-2016-09-737536